San
Francisco, 30 April , Attention Deficit Hyperactivity Disorder (ADHD) Market
Analysis Report By Drug Type (Stimulant, Non-stimulant), By Demographic, By
Distribution Channel (Hospital & Retail Pharmacy), And Segment Forecasts,
2019 - 2025
The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025,
based on a new report by Grand View Research, Inc., exhibiting a 6.4% CAGR
during the forecast period. Increase in awareness regarding ADHD among
patients, physicians, and other healthcare providers is likely to up demand for
effective treatment, in turn, propelling market growth.
Furthermore, there has been a
steady rise in ADHD patients during the last 20 years. According to a study
conducted by the National Health Interview Survey, the prevalence of ADHD among
children and adolescents in U.S. rose from 6.1% in 1997-1998 to 10.2% in
2015-2016.
Approval and commercialization
of drugs, increase in number of clinical trials, and rise in awareness
regarding diagnosis and treatment of the condition is expected to boost market
growth over the forecast period.
Access Full Research
Report On Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis:
Further key findings from the study suggest:
·
Increasing access to health
insurance for mental health treatment and rising incidence of ADHD are expected
to propel market growth in the coming years
·
By drug type, the stimulant
drugs segment accounted for the largest share in the market in 2018 and is
anticipated to maintain its dominance during the forecast period. This can be
attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization
of new drugs
·
Based on demographics, adults
held the maximum share in the ADHD market in 2018 due to high prevalence of the
condition across the globe, increased awareness about mental health, and launch
of effective drugs with minimum adverse effects
·
By distribution channel, retail
pharmacy accounted for the largest share in 2018 due to increasing number of
prescriptions. This can be attributed to rise in patient care initiatives by
retail pharmacies
·
Geographically, North America
dominated the global ADHD market in 2018 owing to high awareness of mental
health, increasing patient population, and local presence of market players
·
Asia Pacific is anticipated to
observe significant growth during the forecast period owing to government
initiatives to provide effective treatment for ADHD and rising patient
population due to stressful lifestyle
·
Some of the key players in the
market are Eli Lily & Company; Pfizer; Johnson & Johnson Services, LLC;
Lupin; Shire; Mallinckrodt; Prude Pharma L.P.; and NEOS Therapeutics Inc.
Browse More Reports Of This Category By
Grand View Research At: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
global ADHD market by drug type, demographic, distribution channel, and region:
ADHD Drug Outlook (Market
Revenue in USD Million, 2014 - 2025)
·
Amphetamine
·
Methylphenidate
·
Lisdexamfetamine
·
Dexmethylphenidate
·
Atomoxetine
·
Guanfacine
·
Clonidine
·
Bupropion
ADHD Drug Type Outlook (Market
Revenue in USD Million, 2014 - 2025)
·
Stimulant
·
Non-stimulant
ADHD Demographic Outlook
(Market Revenue in USD Million, 2014-2025)
·
Adult (Aged 18 and above)
·
Children
ADHD Distribution Channel
Outlook (Market Revenue in USD Million, 2014-2025)
·
Retail Pharmacy
·
Hospital Pharmacy
ADHD Regional Outlook (Market
Revenue in USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
Access Full Press Release of this Report: https://www.grandviewresearch.com/press-release/global-attention-deficit-hyperactivity-disorder-adhd-market
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment